NSCLC, Stage IIIA Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC
NSCLC Stage IINSCLC, Stage IIIANSCLC Stage IIIB
University Hospital Heidelberg20 enrolled1 locationNCT04865250
Recruiting
Phase 2
Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients
NSCLC Stage IINSCLC, Stage IIIANSCLC, Stage I
University Hospital, Essen90 enrolled4 locationsNCT04205552